Longevity Results typically last 1218 months, depending on the filler used and individual factors
Therefore additional studies are needed to determine safety, feasibility, and efficacy
ATCC CCL-81), and HEK293 Flp-In (female human kidney
[124] (Table S2 from Su et al., sheet S2.2 Metabolomics, age-, sex- and BMI-adjusted z-score-transformed plasma metabolite concentrations) and re-analysed the plasma metabolomics data for acetylcarnitine to investigate differences in acetylcarnitine levels between healthy controls and patients with PASC ( 1 PASC symptom according to the clinical information available from Table S1, sheet S1.3 PASC data of Su et al.)
This distinction matters because many cited human data involve epithalamin rather than Epitalon alone
There are few data on treatment efficacy, aside from occasional case reports [93] and case series [94] of adult patients treated with IBATs